In a groundbreaking study that promises to reshape neonatal care protocols for vulnerable infants, particularly those diagnosed with critical congenital heart disease (CCHD), researchers have uncovered compelling evidence that oral care with human milk can significantly enhance the rate of human milk feeding and breastfeeding success. Published in the Journal of Perinatology in April 2026, this research offers a beacon of hope for newborns whose fragile cardiovascular systems pose an immense challenge to optimal nutritional strategies and long-term health outcomes.
Critical congenital heart disease is among the most severe forms of congenital anomalies, often requiring immediate and complex medical intervention following birth. These infants face numerous obstacles to successful feeding, a predicament that not only hampers their growth but also compromises their immune defense and developmental trajectories. Breastfeeding and human milk feeding have long been recognized as vital for supporting infant health, yet infants with CCHD often experience difficulties establishing and maintaining breastfeeding due to factors like delayed oral feeding readiness and procedural interventions.
This recent study undertook a meticulous investigation into the potential benefits of using human milk as an oral care agent—essentially applying expressed human milk to the oral mucosa—as a therapeutic adjunct. The rationale behind this approach stems from the antimicrobial and immunomodulatory properties inherent in human milk, which could foster a more conducive oral environment for feeding and stimulate infants’ reflexes and oral sensory experiences, crucial for feeding skill development.
The research team employed a robust, longitudinal design, enrolling newborns diagnosed with CCHD prior to their cardiac surgeries. These infants received standardized oral care using human milk at regular intervals, monitored over weeks to assess breastfeeding rates, feeding milestones, and overall feeding efficacy. The data revealed a notable uptick in breastfeeding initiation and continuation rates among infants receiving oral care with human milk compared to matched controls receiving standard care devoid of this intervention.
Mechanistically, the findings suggest that the exposure of the oral mucosa to the bioactive components of human milk—such as immunoglobulins, growth factors, and anti-inflammatory agents—may accelerate the maturation of oral tissues and sensory pathways critical for effective suckling. Additionally, the neuroprotective compounds in human milk likely contribute to enhanced neuromuscular coordination necessary for breastfeeding, a process often delayed or impaired in CCHD infants due to neurological compromise associated with hypoxia and surgical stress.
Beyond the immediate clinical benefits, this intervention holds promise for fostering maternal-infant bonding through increased breastfeeding opportunities, thus mitigating the psychological stress that parents often endure when their infants face intensive cardiac care. Enhancing breastfeeding success also aligns with broader public health objectives, reducing the incidence of formula feeding-associated complications such as necrotizing enterocolitis, infections, and adverse metabolic outcomes.
The study’s authors highlight that integrating human milk oral care into neonatal intensive care unit (NICU) protocols is both feasible and cost-effective. Training healthcare providers to administer this simple intervention does not require sophisticated equipment and can be readily adapted across various healthcare settings irrespective of resource availability. Such versatility accentuates its potential for global impact, especially in regions where specialized feeding support for infants with CCHD may be limited.
Notably, the study also addresses potential concerns regarding safety and risk of aspiration, demonstrating through careful monitoring that the oral care procedure does not increase respiratory complications or feeding intolerance. This safety profile is pivotal for gaining clinical acceptance and alleviating hesitations among caregivers and clinicians alike.
Furthermore, the researchers posit that oral care with human milk might counteract the deleterious shifts in oral microbiota composition commonly observed in hospitalized infants, promoting a healthier microbial balance that supports oral and gastrointestinal health. This microbial modulation could underpin some of the observed improvements in feeding capacity and overall infant wellbeing.
While the evidence is compelling, the authors advocate for larger multicenter trials to validate these findings across diverse populations and to explore the intervention’s long-term effects on growth, neurodevelopment, and cardiac outcomes. They also call for mechanistic studies to delineate the specific molecular pathways through which human milk exerts its beneficial effects on oral tissues and feeding reflexes.
This research arrives at a time when neonatal care faces mounting challenges in managing complex conditions like CCHD, where incremental improvements in supportive therapies can translate into significant survival and quality of life gains. By harnessing the innate properties of human milk in a novel application, the study epitomizes innovative, patient-centered care that respects the physiological and emotional needs of both infants and families.
In conclusion, the introduction of oral care with human milk as a standard adjunct to feeding management represents a promising intervention that could revolutionize feeding strategies in neonates with critical congenital heart disease. Its simplicity, safety, and efficacy underscore the importance of continued research into breastfeeding-supportive practices, particularly for the most medically fragile infants. Future investigations expanding on these insights could pave the way for enhanced neonatal nutrition paradigms, ultimately shifting clinical practice towards treatments that are both biologically harmonious and deeply humane.
Subject of Research: The impact of oral care with human milk on feeding and breastfeeding outcomes in newborns with critical congenital heart disease.
Article Title: Oral care with human milk is associated with increased human milk feeding and breastfeeding for newborns with critical congenital heart disease.
Article References:
Elgersma, K.M., Slater, N.L., Watkins, K. et al. Oral care with human milk is associated with increased human milk feeding and breastfeeding for newborns with critical congenital heart disease. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02698-7
Image Credits: AI Generated
DOI: 27 April 2026
Tags: breastfeeding challenges in CCHDcritical congenital heart disease nutritionexpressed human milk therapyhuman milk feeding successhuman milk oral careinfant developmental health and feedingneonatal care protocols 2026neonatal feeding interventionsneonatal immune defense strategiesnewborn breastfeeding supportnutritional support for vulnerable infantsoral mucosa care in infants
